Melody Libby

Company: Biogen

Job title: Patient Advocacy Lead, Alzheimer's

Seminars:

Panel Discussion: Perspectives from Patients & Prescribing Neurologists on the Clinical Adoption of Disease-Modifying Anti-Amyloid Therapeutics 9:00 am

What is the patient burden associated with anti-amyloid therapies and how might these treatments be improved? What are the key factors driving Lecanemab and Donanemab uptake among patients? What are the hesitancies from prescribing neurologists to adapt to these new therapies?Read more

day: Conference Day Two AM